Overview
Circadia Health offers AI-powered contactless patient monitoring for senior care using a radar bedside device to measure respiratory rate, heart rate, motion, and bed exits from up to eight feet away without touching the patient. Its proprietary AI analyzes the data to predict potential medical events hours or days in advance, with 24/7 virtual nurses reviewing alerts and integrating with electronic health records. The service runs on a subscription model for skilled nursing facilities and long-term care providers, and is designed to help reduce hospitalizations and lower costs, with Medicare remote monitoring reimbursement. Its approach combines non-contact radar sensing, multi-parameter monitoring, FDA-cleared devices, and end-to-end service focused on long-term care to shift from reactive to proactive care.
Work here?Claim your company
Simplify's Take
What believers are saying
- CMS selected Circadian Health for ACCESS in April 2026, widening Medicare specialty exposure.
- Ciena's 77-facility partnership and 25% rehospitalization target validate buyer demand.
- FDA cleared C300 in February 2026, extending Circadia's addressable monitoring use cases.
What critics are saying
- CMS ACCESS selection in April 2026 signals care-model breadth, not durable device demand.
- Circadia's remote monitoring economics rely on Medicare RPM billing and facility adoption cycles.
- A single FDA safety, reimbursement, or false-alert setback can stall senior-care expansion.
What makes Circadia Health unique
- FDA-cleared C200 and C300 monitor respiration, heart rate, motion, and bed exits contactlessly.
- Virtual nurses review alerts 24/7, combining radar data with EHR trends for escalation.
- Circadia integrates with skilled nursing workflows and PointClickCare, targeting avoidable rehospitalizations.
Help us improve and share your feedback! Did you find this helpful?